{
  "ptid_time": "073_S_4853_2012-10-23",
  "img_path": "/data/qiuhui/data/adni/images/073_S_4853/2012-10-23/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 49,613 mm³, 76.8% above the reference mean. With a Z-score of 1.76 (96.1th percentile), this represents moderate enlargement; hippocampal volume measures 6,866 mm³, 3.5% below the reference mean. With a Z-score of -0.32 (37.4th percentile), this represents normal volume ; whole brain volume measures 1,080,420 mm³, 10.9% above the reference mean. With a Z-score of 1.37 (91.4th percentile), this represents mild enlargement; entorhinal cortex volume measures 3,191 mm³, 13.1% below the reference mean. With a Z-score of -0.81 (21.0th percentile), this represents normal volume ; fusiform gyrus volume measures 18,133 mm³, 6.6% above the reference mean. With a Z-score of 0.60 (72.5th percentile), this represents normal volume ; middle temporal gyrus volume measures 20,019 mm³, 4.4% above the reference mean. With a Z-score of 0.38 (65.0th percentile), this represents normal volume . ",
  "text_data": "Age is 70.9 years. Gender is Female. Education: 16 years. Handedness: Right. Race: White. Medical history: Cardiovascular; Endocrine-Metabolic; Renal-Genitourinary; Major Surgical Procedures. MMSE: 26.0. MoCA: 23.0. Logical Memory: 5.0. APOEε4 alleles: 1.0. Biomarker levels: Florbetapir (AV45): 1.37 SUVR (significant elevated); Amyloid beta: 691.90 pg/mL (normal ); Total tau: 741.60 pg/mL (profound elevated); Phosphorylated tau: 83.30 pg/mL (profound elevated). ",
  "true_diagnosis": "Diagnosis: AD.",
  "gpt_diagnosis": "**Reasoning:** The patient shows moderate ventricular enlargement (suggesting atrophy) and a normal hippocampal volume, but the entorhinal cortex is slightly reduced. Cognitive scores (MMSE 26, MoCA 23) are borderline, with normal Aβ but profoundly elevated T-tau and P-tau, along with significant AV45 (amyloid PET) positivity, indicating amyloid pathology and neurodegeneration.  \n**Diagnosis:** **Mild Cognitive Impairment (MCI)** (likely prodromal Alzheimer’s given biomarker profile).  \n**Confidence:** **High** (biomarkers strongly support AD pathology, but cognitive decline is not yet severe enough for dementia).  \n\n*Note: The elevated tau and AV45 with borderline cognitive scores suggest early AD progression, but formal dementia criteria are not fully met yet.*",
  "timestamp": "2025-07-26T09:53:51.468148"
}